Tesamorelin + Ipamorelin
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
Tesamorelin +Ipamorelin
Tesamorelin+Ipamorelin · TES+IPA · TP10 · TP12 · TP20
Contact us for current batch testing data on this specification.

Tesamorelin+Ipamorelin is a lyophilized two-peptide research blend of a 44-amino-acid GRF analog and a pentapeptide GHSR ligand.(TES,IPA,TP10,TP12,TP20)
Overview
This blend combines tesamorelin, a synthetic GRF analog, with ipamorelin, a pentapeptide GHSR ligand, as a two-component reference for laboratory peptide research.
Peptides Duo supplies tesamorelin+ipamorelin with full analytical documentation, scalable quantities and dependable worldwide delivery.
What is Tesamorelin+Ipamorelin?
Each vial contains tesamorelin and ipamorelin. Pack strengths: TP10 8 mg+2 mg, TP12 10 mg+2 mg, TP20 16 mg+4 mg. Tesamorelin is a human growth hormone-releasing factor (GRF) analog produced synthetically. It is comprised of the 44 amino acid sequence of human GRF and a hexenoyl moiety, a C6 chain with a double bond at position 3, attached to the N-terminal tyrosine. Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2). For laboratory research use only.
Characterization
Each batch is HPLC-purified and mass-confirmed, with identity, purity and net peptide content documented on the COA.
Key Highlights
- Two-peptide blend: GRF analog + GHSR pentapeptide
- ≥99% purity verified by HPLC & Mass Spectrometry
- Lyophilized solid peptide, good stability
- Third-party tested, research-grade raw material
- For laboratory research use only
Safety & Side Effects
Tesamorelin+Ipamorelin is a lyophilized two-peptide research blend of a 44-amino-acid GRF analog and a pentapeptide GHSR ligand.(TES,IPA,TP10,TP12,TP20) When used in research, Tesamorelin + Ipamorelin should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.
Published tesamorelin + ipamorelin side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for growth hormone secretagogue activity readouts and any off-target effects relevant to the compound’s mechanism when designing a study.
For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.
Dosage & Protocol
There is no standardized human dosage for Tesamorelin + Ipamorelin; it is supplied strictly for laboratory research. Reported tesamorelin + ipamorelin dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.
Research protocols typically document tesamorelin + ipamorelin dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 218949-48-5 / 170851-70-4, molecular formula C221H366N72O67S / C38H49N9O5, molecular weight 5135.9 / 711.9 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.
Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.
Comparison
| Peptide | ReceptorsCore | Characteristic |
|---|---|---|
| Tesamorelin+Ipamorelin | GHRHR+GHSR | GRF analog + pentapeptide GHS |
| Tesamorelin | GHRHR | 44-aa GRF analog (N-hexenoyl) |
| Ipamorelin | GHSR | Pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| CIC-1295 Without DAC | GHRHR | Modified GRF 1-29 analog |
How to Order
Enquiry
Send strength and quantity for a quote.
Quotation
Price, lead time and specification confirmed.
QC & COA
HPLC/LC-MS tested, COA issued.
Delivery
Tracked worldwide shipping.
Specifications
| Product name | Tesamorelin +Ipamorelin |
|---|---|
| Product code | TP10 |
| Specification | (8mg+2mg )*10vials |
| CAS number | 218949-48-5 / 170851-70-4 |
| Molecular formula | C221H366N72O67S / C38H49N9O5 |
| Molecular weight | 5135.9 / 711.9 g/mol |
| Purity | ≥99% (subject to batch COA) |
| Physical Form | lyophilized white solid powder |
| Solubility | Soluble in bacteriostatic water |
Applications
Packaging & Shipping
Available pack sizes
Shipping
Storage & Handling
Store lyophilized at −20 °C, protected from light and moisture. Bring to room temperature before opening. Refrigerate after reconstitution and avoid repeated freeze-thaw cycles.
Product Information Q&A
Can I view the Certificate of Analysis before purchase?
Corresponding batch COA documents are available upon request.
What does “Research Use Only” mean?
This peptide blend is for laboratory research only, not for human or veterinary administration.
How should Tesamorelin+Ipamorelin be shipped and stored?
Shipped as lyophilized powder. Store dry powder at -20°C away from light and humidity.
Additional information
| Specification | (8mg+2mg)*10vials, (10mg+2mg)*10vials, (16mg+4mg)*10vials |
|---|

